Cargando…
The Safety Profile of COVID-19 Vaccines in Patients Diagnosed with Multiple Sclerosis: A Retrospective Observational Study
In the current COVID-19 pandemic, patients diagnosed with multiple sclerosis (MS) are considered to be one of the highest priority categories, being recognized as extremely vulnerable people. For this reason, mRNA-based COVID-19 vaccines are strongly recommended for these patients. Despite encouragi...
Autores principales: | Maniscalco, Giorgia Teresa, Scavone, Cristina, Mascolo, Annamaria, Manzo, Valentino, Prestipino, Elio, Guglielmi, Gaspare, Aiezza, Maria Luisa, Cozzolino, Santolo, Bracco, Adele, Moreggia, Ornella, Di Giulio Cesare, Daniele, Ziello, Antonio Rosario, Falco, Angela, Massa, Marida, Majolo, Massimo, Raiola, Eliana, Soprano, Roberto, Russo, Giuseppe, Longo, Giuseppe, Andreone, Vincenzo, Capuano, Annalisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9692274/ https://www.ncbi.nlm.nih.gov/pubmed/36431332 http://dx.doi.org/10.3390/jcm11226855 |
Ejemplares similares
-
Three Doses of COVID-19 Vaccines: A Retrospective Study Evaluating the Safety and the Immune Response in Patients with Multiple Sclerosis
por: Maniscalco, Giorgia Teresa, et al.
Publicado: (2023) -
Severe Multiple Sclerosis Relapse After COVID-19 Vaccination: A Case Report
por: Maniscalco, Giorgia T., et al.
Publicado: (2021) -
Influenza Vaccine Hesitancy in Patients with Multiple Sclerosis: A Monocentric Observational Study
por: Ziello, Antonio, et al.
Publicado: (2021) -
Hypernatremia During Intravenous Treatment With Fosfomycin: A Retrospective Medical Record Review Study and an Analysis of Spontaneous Reports in the EudraVigilance Database
por: Scavone, Cristina, et al.
Publicado: (2022) -
Humoral efficacy of the third SARS-CoV-2 vaccine dose in Multiple Sclerosis subjects undergoing different disease-modifying therapies
por: Maniscalco, Giorgia Teresa, et al.
Publicado: (2022)